Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

During pregnancy, are newer antiseizure medications safer than older drugs?

Written by | 19 Jul 2025

A new study that examined older and newer medications to treat seizures has found that using some medications during pregnancy is linked to an increased risk of malformations… read more.

New survey reveals need for routine screening and earlier diagnosis for people living with tardive dyskinesia – Neurocrine Biosciences

Written by | 15 Jul 2025

Neurocrine Biosciences, Inc. announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and… read more.

New approach to post-stroke aphasia emerges

Written by | 28 Jun 2025

Researchers report that in patients with chronic aphasia after stroke, right neurotomy of the seventh cervical nerve (C7) at the intervertebral foramen plus intensive speech and language therapy… read more.

Epilepsy in dogs: New advances for diagnosis and research

Written by | 28 Jun 2025

An international research team from the fields of veterinary medicine and genetics has developed a new survey tool to advance canine epilepsy diagnosis and research. Epilepsy and dyskinesia… read more.

Dementia: mood disorders may be early warning sign

Written by | 26 Jun 2025

Growing evidence suggests late-life mood disorders (LLMDs), such as depression and bipolar disorder, could be early warning signs of neurodegenerative diseases like dementia – even when they appear… read more.

Liraglutide could reduce monthly migraine days

Written by | 24 Jun 2025

Liraglutide, a glucagon-like peptide-1 receptor (GLP-1R) agonist used to treat diabetes, appears to reduce monthly migraine days by more than half, researchers reported on June 20, 2025 at… read more.

Alexion to present seven abstracts on gMG and NMOSD at EAN 2025

Written by | 23 Jun 2025

Alexion, AstraZeneca Rare Disease, will present seven abstracts, including four oral presentations, from its leading rare neurology portfolio at the European Academy of Neurology (EAN) Annual Congress in… read more.

Smartphone tests could accelerate drug development for Huntington’s disease

Written by | 17 Jun 2025

A series of digital tests, carried out via a smartphone app, could enhance the detection of disease progression in Huntington’s disease and improve the efficiency of clinical trials,… read more.

NICE (UK) recommends Ontozry (cenobamate) for treating focal onset seizures in epilepsy – Arvelle Therapeutics

Written by | 13 Jun 2025

NICE(UK): Cenobamate is recommended as an option as an add-on treatment for focal onset seizures with or without secondary generalised seizures in adults with drug-resistant epilepsy that has… read more.

New ketamine study promises extended relief for depression

Written by | 4 Jun 2025

Roughly 10 percent of the U.S. population is afflicted with major depressive disorder at any given time, and up to 20 percent will exhibit MDD symptoms over their lifetimes. Yet… read more.

Antidepressant therapy could increase survival in ALS

Written by | 24 May 2025

Antidepressants that suppress REM (rapid eye movement) sleep appear to improve survival in people with amyotrophic lateral sclerosis (ALS). Researchers reported the finding on May 21, 2025 at… read more.

Adolescents who sleep longer perform better at cognitive tasks

Written by | 1 May 2025

Adolescents who sleep for longer – and from an earlier bedtime – than their peers tend to have improved brain function and perform better at cognitive tests, researchers… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.